by Laya Kiani | Aug 15, 2024
According to the World Health Organization (WHO), in 2017, total global spending on health reached US$7.8 trillion and, by 2020, this figure had leapt to $9 trillion as governments raced to contain the first wave of COVID-19. The WHO estimates that worldwide spending...
by Medicine by Design | Aug 6, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
by Stacey Johnson | Aug 2, 2024
He’s back! The regenerative medicine (RM) field’s unofficial mascot – Deadpool – is back in theatres and all over media and social media due to what one must assume is a super(hero)-sized marketing budget. Although some may disagree on his status as a mascot, you...
by Laya Kiani | Jul 18, 2024
In last week’s post, “The role and impact of IP rights on innovation and investment in RM,” I discussed the importance of intellectual property (IP) rights in regenerative medicine (RM), highlighting how they drive innovation and secure competitive advantages....
by Laya Kiani | Jul 11, 2024
Intellectual property (IP) rights in regenerative medicine (RM) are crucial for sparking innovation and staying ahead in a competitive market. Protecting inventions through patents and other IP rights encourages investment by giving inventors exclusive market rights....
by Lyla El-Fayomi | Jun 18, 2024
“Regenerative medicine news under the microscope” is a monthly feature highlighting a selection of impactful research findings and headlines across the many subfields of regenerative medicine. Throughout the past month, I’ve spotted some notable trends emerging in the...
Comments